Aptose Biosciences Inc Cash Flow-to-Debt Ratio
Aptose Biosciences Inc cash flow-to-debt ratio. Aptose Biosciences Inc (APS) has a Cash Flow-to-Debt Ratio of -0.29x as of September 2025, meaning its operating cash flow of CA$-7.41 Million could theoretically repay 0% of its total liabilities (CA$25.79 Million) in one year. Check APS cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aptose Biosciences Inc (1996–2024)
Cash flow-to-debt ratio of Aptose Biosciences Inc from 1996 to 2024. Historical debt coverage capacity for Aptose Biosciences Inc across 29 annual periods. Check APS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Aptose Biosciences Inc Cash Flow-to-Debt Ratio by Year (1996–2024)
Aptose Biosciences Inc cash flow-to-debt ratio by year from 1996 to 2024. Year-by-year debt coverage analysis for Aptose Biosciences Inc. For the full cash flow conversion analysis, see how efficiently does Aptose Biosciences Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.45x | CA$-35.98 Million | CA$14.67 Million | ▲ +12.6% |
| 2023 | -2.81x | CA$-44.59 Million | CA$15.89 Million | ▼ -15.3% |
| 2022 | -2.43x | CA$-32.32 Million | CA$13.29 Million | ▲ +53.4% |
| 2021 | -5.22x | CA$-43.30 Million | CA$8.29 Million | ▼ -13.3% |
| 2020 | -4.61x | CA$-33.89 Million | CA$7.35 Million | ▼ -40.2% |
| 2019 | -3.29x | CA$-21.56 Million | CA$6.55 Million | ▲ +60.4% |
| 2018 | -8.32x | CA$-23.21 Million | CA$2.79 Million | ▼ -43.7% |
| 2017 | -5.79x | CA$-10.22 Million | CA$1.76 Million | ▲ +37.3% |
| 2016 | -9.24x | CA$-12.17 Million | CA$1.32 Million | ▼ -59.0% |
| 2015 | -5.81x | CA$-9.89 Million | CA$1.70 Million | ▼ -17.5% |
| 2014 | -4.95x | CA$-9.94 Million | CA$2.01 Million | ▼ -76.5% |
| 2013 | -2.80x | CA$-4.94 Million | CA$1.76 Million | ▼ -127.0% |
| 2012 | -1.23x | CA$-3.21 Million | CA$2.60 Million | ▲ +75.7% |
| 2011 | -5.09x | CA$-6.03 Million | CA$1.19 Million | ▼ -288.8% |
| 2010 | -1.31x | CA$-3.53 Million | CA$2.70 Million | ▼ -187.9% |
| 2009 | -0.45x | CA$-6.62 Million | CA$14.57 Million | ▲ +31.1% |
| 2008 | -0.66x | CA$-10.25 Million | CA$15.55 Million | ▼ -54.2% |
| 2007 | -0.43x | CA$-5.88 Million | CA$13.76 Million | ▲ +54.1% |
| 2006 | -0.93x | CA$-11.87 Million | CA$12.73 Million | ▲ +28.8% |
| 2005 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +0.0% |
| 2004 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +72.8% |
| 2003 | -4.82x | CA$-20.60 Million | CA$4.28 Million | ▼ -38.8% |
| 2002 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▲ +0.0% |
| 2001 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▼ -110.6% |
| 2000 | -1.65x | CA$-6.28 Million | CA$3.81 Million | ▼ -10.9% |
| 1999 | -1.49x | CA$-3.58 Million | CA$2.41 Million | ▲ +46.3% |
| 1998 | -2.77x | CA$-2.44 Million | CA$881.66K | ▲ +30.8% |
| 1997 | -4.00x | CA$-3.02 Million | CA$755.18K | ▼ -22.2% |
| 1996 | -3.27x | CA$-2.61 Million | CA$798.14K | — |